摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(2-butan-2-yl-3-oxo-2H-imidazo[1,2-c]quinazolin-5-yl)sulfanyl]-N-(3,5-dimethoxyphenyl)propanamide | 1217789-00-8

中文名称
——
中文别名
——
英文名称
2-[(2-butan-2-yl-3-oxo-2H-imidazo[1,2-c]quinazolin-5-yl)sulfanyl]-N-(3,5-dimethoxyphenyl)propanamide
英文别名
——
2-[(2-butan-2-yl-3-oxo-2H-imidazo[1,2-c]quinazolin-5-yl)sulfanyl]-N-(3,5-dimethoxyphenyl)propanamide化学式
CAS
1217789-00-8
化学式
C25H28N4O4S
mdl
——
分子量
480.6
InChiKey
LTVQNKBNTVSKPZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    34
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    118
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • Small molecule regulators of mitochondrial fusion and methods of use thereof
    申请人:Washington University
    公开号:US10844023B2
    公开(公告)日:2020-11-24
    Compositions comprising small molecule mitofusin agonists are described. The mitofusin modulating agents are useful for treating diseases or disorders associated with a mitochondria-associated disease, disorder, or condition such as diseases or disorders associated with mitofusin 1 (Mfn1) and/or mitofusin 2 (Mfn2), or mitochondrial dysfunction. Methods of treatment, pharmaceutical formulations, and screening methods for identifying compounds that regulate mitochondrial function are also described.
    本文描述了包含小分子丝裂霉素激动剂的组合物。丝裂素素调节剂可用于治疗与线粒体相关的疾病、紊乱或病症,如与丝裂素素1(Mfn1)和/或丝裂素素2(Mfn2)或线粒体功能障碍相关的疾病或紊乱。还描述了治疗方法、药物制剂和用于鉴定调节线粒体功能的化合物的筛选方法。
  • SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF
    申请人:Wahington University
    公开号:US20190169138A1
    公开(公告)日:2019-06-06
    Compositions comprising small molecule mitofusin agonists are described. The mitofusin modulating agents are useful for treating diseases or disorders associated with a mitochondria-associated disease, disorder, or condition such as diseases or disorders associated with mitofusin 1 (Mfn1) and/or mitofusin 2 (Mfn2), or mitochondrial dysfunction. Methods of treatment, pharmaceutical formulations, and screening methods for identifying compounds that regulate mitochondrial function are also described.
查看更多